April 5, 2015- Interviewed by Steven E. Greer, MD
Few people knew what a compounding pharmacy was until a meningitis outbreak traced to the New England Compounding Pharmacy made the news in 2012. The facility was filthy, unregulated, and Read more »
August 11, 2014- Interviewed by Steven E. Greer, MD
Above, in Part 1 of our interview with the CEO of Dexcom, Terry Gregg, Read more »
July 5, 2015- Interviewed by Steven E. Greer, MD
We interviewed William Suh, MD of UCLA about the newly approved Edwards Lifesciences Sapien 3 aortic valve. Read more »
July 4, 2015- by Steven E. Greer, MD
I finally saw the acclaimed Clint Eastwood film American Sniper. Bradley Cooper played the character of decorated Navy SEAL sniper Chris Kyle, for which he was nominated Read more »
Interviewed by Steven E. Greer, MD
In Part 1 of our interview with Robert Klitzman, MD, ethics professor at Columbia University, we discuss the 23andMe genetic test kit company and why the FDA made them stop marketing the tests.
March 26, 2015- Interviewed by Steven E. Greer, MD
March 18, 2015- Op-Ed by Steven E. Greer, MD
The American College of Cardiology (ACC) meeting is underway, and the main Late Breaking data making the national news came from the PCSK9-antibody drugs (evolocumab and alirocumab) that dramatically Read more »
January 14, 2015- Interviewed by Steven E. Greer, MD
We interviewed Dr. Shlomo Melmed, Director of the Clinical Research Institute and Dean of Faculty at Read more »
Cedars Sinai LA, Diabetes, Endocrinology, FDA, Gastroenterology/Hepatology, Internal medicine, Neurology, OBGYN, Oncology, Pediatrics, Policy, Preventive Medicine | apples49 | March 19, 2015 4:24 pm | Comments (0)
Opinion December 17, 2013- By Steven E. Greer, MD
The Wall Street Journal published an article explaining how the pharmaceutical industry data mines credit card records, Internet traffic patterns, and other personal data on individuals, then forms educated guesses Read more »